Tai Ching Ho

Tai Ching Ho

Keine laufenden Positionen mehr
64 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Tai Ching Ho is the founder of two companies.
He founded BeiGene Ltd. in 2010 and served as President from 2010 to 2012.
He also founded Metastagen, Inc. in 2013 and served as Chief Executive Officer from 2013 to 2014.
Dr. Ho held several former jobs, including Vice President-Oncology Development at Johnson & Johnson from 2008 to 2010, Chief Medical Officer & Executive Vice President at Epizyme, Inc. from 2015 to 2017, and Senior Vice President-Oncology Center at GlaxoSmithKline LLC.
He was also Chief Medical Officer at Boston Pharmaceuticals, Inc. from 2018 to 2020 and Independent Director at Aravive, Inc. from 2021 to 2024.
Dr. Ho received his undergraduate degree from The Johns Hopkins University and his doctorate from Yale School of Medicine.

Ehemalige bekannte Positionen von Tai Ching Ho

UnternehmenPositionEnde
ARAVIVE, INC. Direktor/Vorstandsmitglied 17.01.2024
Technik-/Wissenschafts-/F&E-Leiter 01.01.2020
EPIZYME, INC. Technik-/Wissenschafts-/F&E-Leiter 31.12.2017
Vorstandsvorsitzender 01.09.2014
BEIGENE LTD Gründer 01.12.2012
Sehen Sie sich die Erfahrung von Tai Ching Ho im Detail an

Ausbildung von Tai Ching Ho

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

46

Beziehungen ersten Grades

9

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen9

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Tai Ching Ho